38 results
8-K
RVMD
Revolution Medicines, Inc.
7 Aug 24
Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress
4:05pm
of Human Health at Merck & Co., Inc. from March 2021 to January 2022. Before that, Mr. Clyburn held various leadership positions at Merck from November
8-K
EX-99.1
RVMD
Revolution Medicines, Inc.
7 Aug 24
Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress
4:05pm
in oncology. The company also expanded its senior management group with key new hires in medical affairs, corporate affairs, drug safety and program leadership … and internal medicine business units at Sanofi Aventis and held several leadership roles within the
company. Mr. Clyburn received his M.B.A. from Arizona
8-K
EX-99.1
szqphq
8 May 23
Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress
4:04pm
8-K
EX-99.1
ufe4gq8t ln6
7 Nov 22
Revolution Medicines Reports Third Quarter 2022 Financial Results and Update on Corporate Progress
4:08pm
8-K
EX-99.1
p7fu2orwrx2x
9 May 22
Revolution Medicines Reports First Quarter 2022 Financial Results and Update on Corporate Progress
4:07pm
8-K
EX-99.1
wa44pj yrbje26til
10 Nov 21
Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress
4:06pm